InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: None

Thursday, 04/06/2017 5:34:39 PM

Thursday, April 06, 2017 5:34:39 PM

Post# of 74527

By 2006, Chris was a successful doctor living in Los Angeles, who owned several clinics and other ventures such as an adult entertainment club. However he ran into financial problems when he was dragged into a federal case, which he was eventually exonerated from.

During his lengthy legal battle, his finances took a major hit and he was unable to find work because of the bad publicity. That was when he started working on the idea for "Santa." He finally completed "Santa," the first of the proposed Kim Kramer series, in 2012.

https://www.amazon.com/Christopher-Otiko/e/B00N1B4AZ6

We know the book didn't sell well, and bring the needed windfall.

We know he lost a lot of money on the Axeman horror flick.

We know he started Coast to Coast in 2011 and likely has welfare/Medicare customers for guaranteed income. That revenue though does not go directly to the public entity created to license products. He can license Viabecline to himself as Coast to Coast. I recall seeing receivables from a third party. I assume it's this clinic.

We know he issued 40M shares of stock to himself in 2014 when he took the business public. We don't know if he and Ekaterina pull an income from the licensing business. I recall the SG&A figure being one of the larger expenses.

ViaDerma showed a Going Concern around Q3 due to a six figure Note coming due. Otiko announced an expected loss in Q4.

The Annual Report for 2016 should indicate costs to produce 500k units of Viabecline, unless this was done this year. It should better explain the business model. Does their income flow from licensing fees for Viabecline? Are they selling to clinics besides Coast to Coast?

If this is a licensing business, why does Otiko imply he is involved in product innovation? Are the new products created thru Phillips in Oklahoma? Does he pay Phillips license fees for the base of these products?

I understand the man's need to earn a living. If he is using shareholder money to grow a business, he needs to do a much better job of presenting how this business operates.